Nexus Company Profile

✉ Email this page to a colleague

NEXUS has twenty approved drugs.

There are five US patents protecting NEXUS drugs. There is one tentative approval on NEXUS drugs.

There are ten patent family members on NEXUS drugs in nine countries and eighty-eight supplementary protection certificates in nine countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nexus	COLISTIMETHATE SODIUM	colistimethate sodium	INJECTABLE;INJECTION	065177-001	Mar 19, 2004	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Nexus	ERYTHROMYCIN LACTOBIONATE	erythromycin lactobionate	INJECTABLE;INJECTION	215290-001	Feb 14, 2022	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Nexus	SODIUM NITROPRUSSIDE	sodium nitroprusside	INJECTABLE;INJECTION	207499-001	May 25, 2017	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Nexus	EMERPHED	ephedrine sulfate	SOLUTION;INTRAVENOUS	213407-001	Apr 17, 2020		RX	Yes	Yes	11,241,400	⤷ Try a Trial				⤷ Try a Trial
Nexus Pharms	SODIUM CHLORIDE 0.9%	sodium chloride	SOLUTION;INJECTION	217535-001	Aug 23, 2023	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Nexus	NELARABINE	nelarabine	INJECTABLE;INTRAVENOUS	215057-001	Jun 2, 2023	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Nexus	TIROFIBAN HYDROCHLORIDE	tirofiban hydrochloride	SOLUTION;INTRAVENOUS	213947-001	Feb 7, 2023	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1713823	1490064-1	Sweden	⤷ Try a Trial	PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
0162036	2000C/032	Belgium	⤷ Try a Trial	PRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329
2203431	2015/009	Ireland	⤷ Try a Trial	PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REGISTRATION NO/DATE: EU/1/14/983 20150115
1110543	08C0004	France	⤷ Try a Trial	PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730
2822954	SPC/GB18/031	United Kingdom	⤷ Try a Trial	PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM.; REGISTERED: UK EU/1/18/1289/001(NI) 20180625; UK EU/1/18/1289/002(NI) 20180625; UK PLGB 11972/0008 20180625
1912999	2014/058	Ireland	⤷ Try a Trial	PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REGISTRATION NO/DATE: EU/1/14/924/001-002 20140516
0294114	55/2007	Austria	⤷ Try a Trial	PRODUCT NAME: NELARABINE; REGISTRATION NO/DATE: EU/1/07/403/001 20070822
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.